Considering our tumor cell–intrinsic data, TCGA data, and that modulation of CBX2 is directly involved in immune transcriptional signatures, we evaluated CBX2 expression using immune cell imputation analyses (e.g., CIBERSORT, XCELL, and TIDE) to define the correlation between CBX2 expression and multiple immune cell types in 303 ovarian cancer tumors within TCGA database (37). The gene discussed is CBX2; the disease is neoplasm.